Sponsor:
Children's Hospital of Philadelphia
Code:
NCT06458036
Conditions
Differentiated Thyroid Cancer
Pediatric Cancer
Cancer
Cancer, Thyroid
Eligibility Criteria
Sex: All
Age: 2 - 21
Healthy Volunteers: Not accepted
Interventions
Selpercatinib Monotherapy
131I Therapy
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-23. This information was provided to ClinicalTrials.gov by Children's Hospital of Philadelphia on 2025-08-01.